|
Hester Biosciences Ltd.
|
Cash Flow
|
|
|
You can view the
Cash Flow
for the last 5 years.
|
Market Cap. (Rs.)
|
1542.21 Cr.
|
P/BV
|
5.11
|
Book Value (Rs.)
|
354.81
|
|
52 Week High/Low (Rs.)
|
3379/1243
|
FV/ML
|
10/1
|
P/E(X)
|
56.11
|
|
Bookclosure
|
29/08/2024
|
EPS (Rs.)
|
32.31
|
Div Yield (%)
|
0.39
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| Net Profit/Loss Before Extraordinary Items And Tax | 39.57 | 31.95 | 40.15 | 53.50 | 50.10 |
| | | | | | |
| Net CashFlow From Operating Activities | 64.51 | 48.13 | 23.60 | 8.81 | 58.05 |
| Net Cash Used In Investing Activities | -19.00 | -22.65 | -77.00 | -116.59 | -38.37 |
| Net Cash Used From Financing Activities | -51.72 | -26.05 | 41.76 | 111.61 | -18.22 |
| Foreign Exchange Gains / Losses | -0.51 | 0.16 | 0.05 | -0.35 | -3.72 |
| | | | | | |
| Net Inc/Dec In Cash And Cash Equivalents | -6.72 | -0.41 | -11.59 | 3.48 | -2.26 |
| Cash And Cash Equivalents Begin of Year | 12.31 | 13.16 | 24.75 | 21.27 | 23.53 |
| Cash And Cash Equivalents End Of Year | 5.59 | 12.75 | 13.16 | 24.75 | 21.27 |
